5-Fluorouracil biomarkers in pancreatic neuroendocrine tumours

Pancreatology. 2017 Jul-Aug;17(4):527-528. doi: 10.1016/j.pan.2017.06.004. Epub 2017 Jun 8.

Authors

Louis de Mestier¹, Jérôme Cros², Pascal Hammel³

Affiliations

¹ Department of Gastroenterology and Pancreatology, Beaujon University Hospital, AP-HP and University Paris 7 - Denis Diderot, Clichy, France. Electronic address: louis.demestier@aphp.fr.
² Department of Pathology, Beaujon University Hospital, AP-HP and University Paris 7 - Denis Diderot, Clichy, France.
³ Department of Digestive Oncology, Beaujon University Hospital, AP-HP and University Paris 7 - Denis Diderot, Clichy, France.

PMID: 28619285
DOI: 10.1016/j.pan.2017.06.004

No abstract available

Keywords: 5-Fluorouracil; Chemotherapy; Dihydropyrimidine-dehydrogenase; Neuroendocrine tumour; Thymidylate synthase.

Publication types

Editorial